Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	NF-kappa B signaling pathway	8/104	2.532090777252779e-14	2.557411685025307e-12	332.1666666666667	-508.6816487300647	IKBKB;IKBKG;NFKB1;NFKB2;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	7/70	3.17265240693019e-13	1.602189465499746e-11	296.48148148148147	-543.3492298155751	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Epstein-Barr virus infection	8/202	5.746190027058594e-12	1.1607303854658359e-10	162.35051546391753	-360.72500267815576	IKBKB;IKBKG;NFKB1;NFKB2;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	7/104	5.559862940056923e-12	1.1607303854658359e-10	191.7422680412371	-443.0178139513241	IKBKB;IKBKG;NFKB1;NFKB2;NFKBIA;RELA;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	7/104	5.559862940056923e-12	1.1607303854658359e-10	191.7422680412371	-443.0178139513241	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	TNF signaling pathway	7/112	9.456753392875718e-12	1.5918868211340793e-10	176.95555555555555	-425.82830401177193	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Osteoclast differentiation	7/127	2.321028491021954e-11	3.348912537045962e-10	154.54444444444445	-397.1247528146288	IKBKB;IKBKG;NFKB1;NFKB2;NFKBIA;RELA;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	6/63	3.615346591682112e-11	4.564375071998666e-10	210.81578947368422	-483.8921864592378	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1
KEGG_2021_Human	Apoptosis	7/142	5.137659816443608e-11	5.76559601623116e-10	137.11358024691359	-371.51654074403336	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Adipocytokine signaling pathway	6/69	6.362284067331453e-11	6.425906908004768e-10	190.5952380952381	-458.23071562132344	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Hepatitis C	7/157	1.0476446292189941e-10	9.619282504647128e-10	123.16888888888889	-347.9834861622325	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	7/181	2.8649990086944273e-10	2.411374165651143e-09	105.85823754789271	-313.9653002169225	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	IL-17 signaling pathway	6/94	4.275315894999334e-10	3.321591579961021e-09	136.02272727272728	-370.83086239351786	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Pathogenic Escherichia coli infection	7/197	5.206222118571e-10	3.755917385540507e-09	96.74736842105263	-293.8069056444345	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Chagas disease	6/102	7.046291742066198e-10	4.744503106324573e-09	124.5625	-348.54374361636394	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	T cell receptor signaling pathway	6/104	7.933426225711089e-10	5.007975304980125e-09	121.98979591836735	-343.35038043058773	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	7/212	8.725556739513963e-10	5.184007239358295e-09	89.49756097560976	-276.7225849395715	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	7/219	1.096335093153288e-09	6.15165802269345e-09	86.46540880503144	-269.3202168862762	IKBKB;IKBKG;NFKB1;NFKB2;NFKBIA;RELA;TNF
KEGG_2021_Human	Toxoplasmosis	6/112	1.2465511520049882e-09	6.626403492237042e-09	112.66981132075472	-323.96040316805903	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Human cytomegalovirus infection	7/225	1.3254937526658181e-09	6.693743450962381e-09	84.02140672782875	-263.24807342748943	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Shigellosis	7/246	2.47817390757487e-09	1.1918836412621995e-08	76.43375174337517	-243.81789201805046	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Salmonella infection	7/249	2.697747821873811e-09	1.2385115000420678e-08	75.4573002754821	-241.25541145806972	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;RIPK1;TNF
KEGG_2021_Human	Legionellosis	5/57	3.5877996201909306e-09	1.5755120071273216e-08	154.15384615384616	-361.8273890688762	NFKB1;NFKB2;NFKBIA;RELA;TNF
KEGG_2021_Human	Yersinia infection	6/137	4.23641592119837e-09	1.782825033504314e-08	90.88167938931298	-275.117151721274	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	5/70	1.0300956143193924e-08	4.161586281850345e-08	123.12307692307692	-308.3116784019305	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Hepatitis B	6/162	1.1657637504621833e-08	4.5285437998723275e-08	76.07692307692308	-238.99790749378803	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Chronic myeloid leukemia	5/76	1.5675128124076017e-08	5.863659039006214e-08	112.63380281690141	-288.85723035226965	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Influenza A	6/172	1.671886438631681e-08	6.030733225064278e-08	71.40361445783132	-227.05657761700246	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	B cell receptor signaling pathway	5/81	2.1682433941956327e-08	7.551468372888239e-08	105.15789473684211	-274.51345395083786	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	5/89	3.498026865447124e-08	1.1776690447005319e-07	95.04761904761905	-254.42375029306876	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Small cell lung cancer	5/92	4.137903491064283e-08	1.3060257893671645e-07	91.73563218390805	-247.65691977347956	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Th1 and Th2 cell differentiation	5/92	4.137903491064283e-08	1.3060257893671645e-07	91.73563218390805	-247.65691977347956	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Prostate cancer	5/97	5.4085780869589264e-08	1.6553526872207624e-07	86.69565217391305	-237.1712976551275	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Lipid and atherosclerosis	6/215	6.372447911498552e-08	1.8929918795922166e-07	56.40430622009569	-186.7350241167357	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Th17 cell differentiation	5/107	8.875508356321046e-08	2.561218125681216e-07	78.09803921568627	-218.72241114395115	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Insulin resistance	5/108	9.301509924721515e-08	2.6095902844357585e-07	77.33009708737865	-217.0379338970056	IKBKB;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Coronavirus disease	6/232	1.0038183269047773e-07	2.7401527301995273e-07	52.04867256637168	-174.3857646205266	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Measles	5/139	3.301250436176135e-07	8.549392155225375e-07	59.208955223880594	-175.30198917758304	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Fluid shear stress and atherosclerosis	5/139	3.301250436176135e-07	8.549392155225375e-07	59.208955223880594	-175.30198917758304	IKBKB;IKBKG;NFKB1;RELA;TNF
KEGG_2021_Human	MAPK signaling pathway	6/294	4.1027904082915563e-07	1.035954578093618e-06	40.520833333333336	-140.03790468986205	IKBKB;IKBKG;NFKB1;NFKB2;RELA;TNF
KEGG_2021_Human	Acute myeloid leukemia	4/67	8.744364582866104e-07	2.1540995679743328e-06	84.70899470899471	-190.62775527188097	IKBKB;IKBKG;NFKB1;RELA
KEGG_2021_Human	Pancreatic cancer	4/76	1.4558243895816926e-06	3.5009110320893086e-06	74.03703703703704	-172.05130589538587	IKBKB;IKBKG;NFKB1;RELA
KEGG_2021_Human	Leishmaniasis	4/77	1.5346775084568718e-06	3.604707636142885e-06	73.01369863013699	-170.21630123625883	NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Chemokine signaling pathway	5/192	1.6475564077590864e-06	3.7818908450833577e-06	42.144385026737964	-131.72377772149218	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	5/193	1.6904863123009375e-06	3.7942026120532155e-06	41.91489361702128	-131.10253044151457	IKBKB;IKBKG;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Viral carcinogenesis	5/203	2.170445025276202e-06	4.765542338106443e-06	39.74747474747475	-125.18223834284193	IKBKG;NFKB1;NFKB2;NFKBIA;RELA
KEGG_2021_Human	Neurotrophin signaling pathway	4/119	8.781438908516766e-06	1.887075169702539e-05	46.10434782608696	-117.80575201518995	IKBKB;NFKB1;NFKBIA;RELA
KEGG_2021_Human	Herpes simplex virus 1 infection	6/498	9.044529937904887e-06	1.9031198411008202e-05	23.097560975609756	-82.2468690367685	IKBKB;IKBKG;NFKB1;NFKBIA;RELA;TNF
KEGG_2021_Human	Pathways in cancer	6/531	1.3121529753006265e-05	2.70464184704823e-05	21.55142857142857	-76.68025045813094	IKBKB;IKBKG;NFKB1;NFKB2;NFKBIA;RELA
KEGG_2021_Human	Human papillomavirus infection	5/331	2.3833262795393072e-05	4.814319084669401e-05	23.74846625766871	-77.98718048580317	IKBKB;IKBKG;NFKB1;RELA;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	4/155	2.5031430482156457e-05	4.957204860191769e-05	34.95364238410596	-93.05983781717019	IKBKB;NFKB1;RELA;TNF
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.00011133746026960828	55.34101382488479	-100.98537671170521	NFKB1;RELA;TNF
KEGG_2021_Human	Pertussis	3/76	9.159620399517935e-05	0.00017455125667005875	46.93737769080235	-88.55605413655218	NFKB1;RELA;TNF
KEGG_2021_Human	Ras signaling pathway	4/232	0.00012150057084905025	0.00022725106769914955	22.923976608187136	-63.412309433922275	IKBKB;IKBKG;NFKB1;RELA
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0003808731135169878	35.2179675994109	-69.8003308229761	NFKB1;RELA;TNF
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0003966863941332615	34.497835497835496	-68.58379435140506	NFKB1;RELA;TNF
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.0006146440625887206	29.379310344827587	-59.68521503911596	NFKB1;RELA;TNF
KEGG_2021_Human	Relaxin signaling pathway	3/129	0.00043986806704120836	0.0007659771512269318	27.01360544217687	-55.40965280021221	NFKB1;NFKBIA;RELA
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.001056291339574915	14.700952380952382	-40.688114366493096	IKBKB;IKBKG;NFKB1;RELA
KEGG_2021_Human	Alzheimer disease	4/369	0.0007223109472324288	0.0012158900945079217	14.069406392694065	-38.837531411044004	IKBKB;NFKB1;RELA;TNF
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.0019263324975556584	19.106537530266344	-40.222430877266724	NFKB1;RELA;TNF
KEGG_2021_Human	Type II diabetes mellitus	2/46	0.0013867643520264008	0.002259083863784943	45.59090909090909	-53.767249912981214	IKBKB;TNF
KEGG_2021_Human	Cocaine addiction	2/49	0.0015725648721553246	0.002521096064883933	42.66489361702128	-51.011826705781694	NFKB1;RELA
KEGG_2021_Human	cAMP signaling pathway	3/216	0.001968898347391993	0.003107167704477989	15.804828973843058	-33.39161145354852	NFKB1;NFKBIA;RELA
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.004948781451943142	29.41176470588235	-37.553176952571945	NFKB1;RELA
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.010177811811970444	19.92	-26.61700675496218	NFKB1;RELA
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.011403604705532307	18.600467289719628	-24.98176436194636	NFKB1;RELA
KEGG_2021_Human	mTOR signaling pathway	2/154	0.014697151111795944	0.021829592092520445	13.019736842105264	-17.666924126955095	IKBKB;TNF
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.022048299060019014	12.847402597402597	-17.429441058365175	NFKB1;RELA
KEGG_2021_Human	Necroptosis	2/159	0.015618487202540639	0.02253524582080864	12.597133757961783	-17.083187709957596	RIPK1;TNF
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.025281532380044967	6.897094430992736	-13.07371705691191	NFKB1;RELA;TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.030379105514030023	10.536096256684491	-14.167050995225416	NFKB1;RELA
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.030862966151525482	10.365789473684211	-13.920708621090329	NFKB1;RELA
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.033797239069709516	9.784825870646767	-13.073912909097736	NFKB1;RELA
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.045168442363444264	8.26054852320675	-10.803362590978235	NFKB1;RELA
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.050155167314613634	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.05888861265131414	24.790123456790123	-13.876145105511855	TNF
KEGG_2021_Human	Primary immunodeficiency	1/38	0.046083072411820386	0.05891633308346657	24.117117117117118	-13.560364723090352	IKBKG
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.05891633308346657	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	Graft-versus-host disease	1/42	0.05082096328161841	0.06416146614304324	21.75338753387534	-12.4264883862275	TNF
KEGG_2021_Human	Type I diabetes mellitus	1/43	0.052002121863896134	0.06484215195374703	21.232804232804234	-12.171283962486152	TNF
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.0538910819803677	0.06637804000020898	6.298701298701299	-7.775300015246377	IKBKB;NFKB1
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.07329589616981369	18.183673469387756	-10.63265628196324	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.09637124682201471	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Mitophagy	1/68	0.0811045146521906	0.09637124682201471	13.26865671641791	-7.96724592924887	RELA
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.10865546142667765	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.12311177697218548	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.1254166906591293	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.1254166906591293	9.632850241545894	-5.8073541800756905	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.126522260971427	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Hematopoietic cell lineage	1/99	0.11607356788707196	0.1286447801997903	9.036281179138323	-5.434068642481248	TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.1286447801997903	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.16214797106544576	6.7846153846153845	-3.968927686510734	TNF
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.16214797106544576	6.7846153846153845	-3.968927686510734	IKBKB
KEGG_2021_Human	Systemic lupus erythematosus	1/135	0.15517650047822218	0.16497712156105726	6.5787728026534	-3.830244937455702	TNF
KEGG_2021_Human	Insulin signaling pathway	1/137	0.15730251033809037	0.16549534941819924	6.480392156862745	-3.763669230249352	IKBKB
KEGG_2021_Human	Breast cancer	1/147	0.16786050842791683	0.1747825912496866	6.0289193302891935	-3.455697502915966	NFKB2
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.23372609447212941	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.2969459698888047	3.184640522875817	-1.4307154955453085	TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3139163756964759	2.9380196523053668	-1.2513063817932166	TNF
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
